BRIEF-Catalyst Pharmaceuticals updates on trial for patients with congenital myasthenic syndromes By: Reuters: Company News December 08, 2016 at 08:40 AM EST * "Continue to believe that we will report top-line results from this study in second half of 2017" Read More >> Related Stocks: Catalyst Pharm Inc
